Occam Places Eva Jack as COO of Hotspot
HotSpot is a private biotech and an investment of Atlas Venture. The company recently raised $100M in a Series C financing and has a platform addressing a number of major disease states including oncology and rare diseases.
In late 2020, Occam recruited Eva Jack, previously CBO of Mersana Therapeutics, to be the COO in a role that would also encompass Business Development.
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.